SCHEMBL14884173

SCHEMBL14884173

CC1(C)OB(c2ccc3c(ccc4c3ccc3c5cccnc5ccc34)n2)OC1(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ CYP3A4 P08684 1/20 0.42
▸ LMNA P02545 3/20 0.41
▸ HTT P42858 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ HSP90AB1 P08238 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ NCOA1 Q15788 2/20 0.39
▸ NCOA3 Q9Y6Q9 1/20 0.38
▸ CYP1A2 P05177 2/20 0.36
▸ CYP1B1 Q16678 2/20 0.36
▸ LPL P06858 1/20 0.34
▸ LIPG Q9Y5X9 1/20 0.34
▸ CYP1A1 P04798 1/20 0.34
▸ EGFR P00533 1/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14884170 1.00 MAPT (0.46) MAPTKDM4ECYP3A4LMNAHTT
SCHEMBL14884175 0.92 CYP3A4 (0.42) MAPTKDM4ECYP3A4LMNAHTT
SCHEMBL14884186 0.91 CYP3A4 (0.40) MAPTKDM4ECYP3A4LMNAHTT
SCHEMBL20769136 0.85 ALDH1A1 (0.37) MAPTKDM4ECYP3A4LMNAHTT
SCHEMBL14884171 0.78 ALDH1A1 (0.36) MAPTKDM4ECYP3A4LMNAHTT
SCHEMBL14884185 0.77 ALDH1A1 (0.39) MAPTKDM4ECYP3A4LMNAHTT
SCHEMBL14884187 0.77 ALDH1A1 (0.39) MAPTKDM4ECYP3A4LMNAHTT
SCHEMBL14884188 0.76 ALDH1A1 (0.41) MAPTKDM4ECYP3A4LMNAHTT
SCHEMBL14884184 0.76 ALDH1A1 (0.41) MAPTKDM4ECYP3A4LMNAHTT
SCHEMBL14884190 0.76 CCR1 (0.41) MAPTKDM4ECYP3A4LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9005777-B2 Heterocyclic compound, organic light-emitting diode including the heterocyclic compound, and flat display device including the organic light-emitting diode SAMSUNG DISPLAY CO., LTD. (KR) 2015-04-14 — — US disclosed
US-9005777-B2 Heterocyclic compound, organic light-emitting diode including the heterocyclic compound, and flat display device including the organic light-emitting diode SAMSUNG DISPLAY CO., LTD. (KR) 2015-04-14 — — US disclosed
US-20130099206-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING THE HETEROCYCLIC COMPOUND, AND FLAT DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT-EMITTING DIODE SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-04-25 — — US disclosed
US-20130099206-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING THE HETEROCYCLIC COMPOUND, AND FLAT DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT-EMITTING DIODE SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130099206-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE INCLUDING THE HETEROCYCLIC COMPOUND, AND FLAT DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT-EMITTING DIODE DRD1, HTR1D, DRD4 MAPT 1433/4885KDM4E 2137/4885CYP3A4 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback